CCMH
CORT icon

Cornerstone Capital Management Holdings’s Corcept Therapeutics CORT Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.59M Sell
88,400
-16,600
-16% -$301K 0.01% 819
2017
Q3 		$2.02M Buy
105,000
+76,500
+268% +$1.14M 0.02% 742
2017
Q2 		$336K Sell
28,500
-8,200
-22% -$89.1K ﹤0.01% 1082
2017
Q1 		$402K Buy
+36,700
New +$322K ﹤0.01% 1092
2016
Q1 		– Sell
-28,200
Closed -$140K – 1502
2015
Q4 		$140K Sell
28,200
-200
-0.7% -$902 ﹤0.01% 1270
2015
Q3 		$107K Buy
+28,400
New +$144K ﹤0.01% 1326

Other funds holding CORT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Cornerstone Capital Management Holdings's CORT Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Corcept Therapeutics (CORT) stake by 16% in Q4 2017, selling an estimated $301K and leaving 88,400 shares worth $1.59M. The position accounts for 0.01% of the portfolio, ranked #819.

Cornerstone Capital Management Holdings first reported a position in CORT in Q3 2015 and has held it in 6 quarters since. The position peaked at $2.02M in Q3 2017. 190 funds tracked by Wall St. Rank hold CORT as of Q4 2017.

  • Cornerstone Capital Management Holdings held 88,400 shares of Corcept Therapeutics worth $1.59M as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 16,600 Corcept Therapeutics shares in Q4 2017, an estimated $301K.
  • Corcept Therapeutics made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #819 holding.
  • Cornerstone Capital Management Holdings first reported a position in Corcept Therapeutics in Q3 2015 and has held it in 6 quarters since.
  • Cornerstone Capital Management Holdings's Corcept Therapeutics position peaked at $2.02M in Q3 2017.
  • 190 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.